Retraction to: Over-expression of FoxM1 leads to epithelial–mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells (J Cell Biochem, 2011, 112, (2296-2306), 10.1002/jcb.23150);Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells

Journal of Cellular Biochemistry

Volumn 112, Issue 9, 2011, Pages 2296-2306

  Bao, Bin ^a   Wang, Zhiwei ^a   Ali, Shadan ^b   Kong, Dejuan ^a   Banerjee, Sanjeev ^a   Ahmad, Aamir ^a   Li, Yiwei ^a   Azmi, Asfar S ^a   Miele, Lucio ^c   Sarkar, Fazlul H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

CSC self renewal; EMT phenotype; FoxM1; Genistein; miRNAs

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; FORKHEAD BOX PROTEIN M1; FORKHEAD TRANSCRIPTION FACTOR; GENISTEIN; HERMES ANTIGEN; MICRORNA; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; ZINC FINGER PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER STEM CELL; CELL INVASION; CELL MIGRATION; CLONOGENESIS; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; PANCREAS CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84860390076     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25588     Document Type: Erratum

References (50)

1. Ali S, Ahmad A, Banerjee S, Padhye S, Dominiak K, Schaffert JM, Wang Z, Philip PA, Sarkar FH,. 2010. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res 70: 3606-3617.
2. Bektas N, Haaf A, Veeck J, Wild PJ, Luscher-Firzlaff J, Hartmann A, Knuchel R, Dahl E,. 2008. Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer. BMC Cancer 8: 42.
3. Bindels S, Mestdagt M, Vandewalle C, Jacobs N, Volders L, Noel A, Van RF, Berx G, Foidart JM, Gilles C,. 2006. Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 25: 4975-4985.
4. Brabletz S, Bajdak K, Meidhof S, Burk U, Niedermann G, Firat E, Wellner U, Dimmler A, Faller G, Schubert J, Brabletz T,. 2011. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J 30 (4): 770-782.
5. Cano A, Nieto MA,. 2008. Non-coding RNAs take centre stage in epithelial-to-mesenchymal transition. Trends Cell Biol 18: 357-359.
6. Christiansen JJ, Rajasekaran AK,. 2006. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66: 8319-8326. (Pubitemid 44449137)
7. Creighton CJ, Chang JC, Rosen JM,. 2010. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia 15: 253-260.
8. Desmouliere A,. 1995. Factors influencing myofibroblast differentiation during wound healing and fibrosis. Cell Biol Int 19: 471-476.
9. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M, Berx G, Cano A, Beug H, Foisner R,. 2005. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24: 2375-2385. (Pubitemid 40546696)
10. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM,. 2006. MicroRNA expression and function in cancer. Trends Mol Med 12: 580-587. (Pubitemid 44780201)
11. Graham TR, Zhau HE, Odero-Marah VA, Osunkoya AO, Kimbro KS, Tighiouart M, Liu T, Simons JW, O'Regan RM,. 2008. Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res 68: 2479-2488. (Pubitemid 351521824)
12. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ,. 2008a. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601. (Pubitemid 351627379)
13. Gregory PA, Bracken CP, Bert AG, Goodall GJ,. 2008b. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 7: 3112-3118.
14. Hermann PC, Bhaskar S, Cioffi M, Heeschen C,. 2010. Cancer stem cells in solid tumors. Semin Cancer Biol 20: 77-84.
15. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW,. 2007. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 213: 374-383. (Pubitemid 47509716)
16. Ischenko I, Seeliger H, Kleespies A, Angele MK, Eichhorn ME, Jauch KW, Bruns CJ,. 2010. Pancreatic cancer stem cells: New understanding of tumorigenesis, clinical implications. Langenbecks Arch Surg 395: 1-10.
17. Kalin TV, Wang IC, Ackerson TJ, Major ML, Detrisac CJ, Kalinichenko VV, Lyubimov A, Costa RH,. 2006. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res 66: 1712-1720. (Pubitemid 43259956)
18. Katoh M, Katoh M,. 2004. Human FOX gene family (review). Int J Oncol 25: 1495-1500.
19. Kim IM, Ackerson T, Ramakrishna S, Tretiakova M, Wang IC, Kalin TV, Major ML, Gusarova GA, Yoder HM, Costa RH, Kalinichenko VV,. 2006. The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res 66: 2153-2161.
20. Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, Sarkar FH,. 2010. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One 5: e12445.
21. Kong D, Li Y, Wang Z, Banerjee S, Ahmad A, Kim HR, Sarkar FH,. 2009. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 27: 1712-1721.
22. Kong D, Li Y, Wang Z, Banerjee S, Sarkar FH,. 2007. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer. Cancer Res 67: 3310-3319. (Pubitemid 46724870)
23. Kong D, Wang Z, Sarkar SH, Li Y, Banerjee S, Saliganan A, Kim HR, Cher ML, Sarkar FH,. 2008. Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells. Stem Cells 26: 1425-1435.
24. Korpal M, Lee ES, Hu G, Kang Y,. 2008. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283: 14910-14914.
25. Laoukili J, Kooistra MR, Bras A, Kauw J, Kerkhoven RM, Morrison A, Clevers H, Medema RH,. 2005. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 7: 126-136. (Pubitemid 40268127)
26. Laoukili J, Stahl M, Medema RH,. 2007. Fox M1: At the crossroads of ageing and cancer. Biochim Biophys Acta 1775: 92-102.
27. Lee CJ, Dosch J, Simeone DM,. 2008. Pancreatic cancer stem cells. J Clin Oncol 26: 2806-2812.
28. Leung TW, Lin SS, Tsang AC, Tong CS, Ching JC, Leung WY, Gimlich R, Wong GG, Yao KM,. 2001. Over-expression of FoxM1 stimulates cyclin B1 expression. FEBS Lett 507: 59-66. (Pubitemid 33000299)
29. Li Q, Zhang N, Jia Z, Le X, Dai B, Wei D, Huang S, Tan D, Xie K,. 2009a. Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res 69: 3501-3509.
30. Li Y, VandenBoom TG, Kong D, Wang Z, Ali S, Philip PA, Sarkar FH,. 2009b. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 69: 6704-6712.
31. Li Y, VandenBoom TG, Kong D, Wang Z, Ali S, Philip PA, Sarkar FH,. 2009c. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 69: 6704-6712.
32. Mahato R, Qin B, Cheng K,. 2010. Blocking IKKalpha expression inhibits prostate cancer invasiveness. Pharm Res. In press (PMID: 21191633).
33. Park SH, Cheung LW, Wong AS, Leung PC,. 2008a. Estrogen regulates snail and slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. Mol Endocrinol 22: 2085-2098.
34. Park SM, Gaur AB, Lengyel E, Peter ME,. 2008b. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907. (Pubitemid 351482843)
35. Peinado H, Olmeda D, Cano A,. 2007. Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428. (Pubitemid 46809165)
36. Peter ME,. 2009. Let-7 and miR-200 microRNAs: Guardians against pluripotency and cancer progression. Cell Cycle 8: 843-852.
37. Regenbrecht CR, Jung M, Lehrach H, Adjaye J,. 2008. The molecular basis of genistein-induced mitotic arrest and exit of self-renewal in embryonal carcinoma and primary cancer cell lines. BMC Med Genom 1: 49.
38. Sarkar FH, Adsule S, Padhye S, Kulkarni S, Li Y,. 2006. The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy. Mini Rev Med Chem 6: 401-407.
39. Sarkar FH, Li Y, Wang Z, Kong D,. 2009. Pancreatic cancer stem cells and EMT in drug resistance and metastasis. Minerva Chir 64: 489-500.
40. Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, Sultan A, Hlubek F, Jung A, Strand D, Eger A, Kirchner T, Behrens J, Brabletz T,. 2008. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 68: 537-544. (Pubitemid 351380082)
41. Vandewalle C, Comijn J, De CB, Vermassen P, Bruyneel E, Andersen H, Tulchinsky E, Van RF, Berx G,. 2005. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acid Res 33: 6566-6578. (Pubitemid 41806421)
42. Wang X, Hung NJ, Costa RH,. 2001. Earlier expression of the transcription factor HFH-11B diminishes induction of p21(CIP1/WAF1) levels and accelerates mouse hepatocyte entry into S-phase following carbon tetrachloride liver injury. Hepatology 33: 1404-1414. (Pubitemid 32496977)
43. Wang X, Krupczak-Hollis K, Tan Y, Dennewitz MB, Adami GR, Costa RH,. 2002. Increased hepatic Forkhead Box M1B (FoxM1B) levels in old-aged mice stimulated liver regeneration through diminished p27Kip1 protein levels and increased Cdc25B expression. J Biol Chem 277: 44310-44316. (Pubitemid 36157865)
44. Wang Z, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH,. 2010a. Forkhead box M1 transcription factor: A novel target for cancer therapy. Cancer Treat Rev 36: 151-156.
45. Wang Z, Banerjee S, Kong D, Li Y, Sarkar FH,. 2007. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res 67: 8293-8300. (Pubitemid 47395167)
46. Wang Z, Li Y, Ahmad A, Azmi AS, Kong D, Banerjee S, Sarkar FH,. 2010b. Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. Drug Resist Updat 13: 109-118.
47. Wang Z, Li Y, Ahmad A, Banerjee S, Azmi AS, Kong D, Wojewoda C, Miele L, Sarkar FH,. 2011. Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells. J Cell Biochem 112: 78-88.
48. Wang Z, Li Y, Banerjee S, Sarkar FH,. 2008. Exploitation of the Notch signaling pathway as a novel target for cancer therapy. Anticancer Res 28: 3621-3630.
49. Wang Z, Li Y, Kong D, Ahmad A, Banerjee S, Sarkar FH,. 2010c. Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. Cancer Lett 292: 141-148.
50. Yang J, Weinberg RA,. 2008. Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell 14: 818-829. (Pubitemid 351757205)